Compare SSB & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSB | ARWR |
|---|---|---|
| Founded | 1933 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 10.1B |
| IPO Year | 2008 | 2009 |
| Metric | SSB | ARWR |
|---|---|---|
| Price | $99.77 | $64.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $118.92 | $81.50 |
| AVG Volume (30 Days) | 845.3K | ★ 2.7M |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | 12.91 | ★ 99.80 |
| EPS | ★ 7.87 | 0.22 |
| Revenue | N/A | ★ $16,142,321.00 |
| Revenue This Year | $9.63 | N/A |
| Revenue Next Year | $6.37 | N/A |
| P/E Ratio | ★ $12.52 | $287.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $77.74 | $10.66 |
| 52 Week High | $108.46 | $76.76 |
| Indicator | SSB | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 51.54 |
| Support Level | $99.00 | $60.53 |
| Resistance Level | $100.26 | $65.59 |
| Average True Range (ATR) | 3.43 | 2.68 |
| MACD | -0.80 | 0.01 |
| Stochastic Oscillator | 30.99 | 87.05 |
SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.